• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720081-01
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problems Pain (1994); Urinary Frequency (2275); Discomfort (2330)
Event Date 10/04/2023
Event Type  Injury  
Event Description
It was reported that the patient experienced discomfort and pain because the length of the implanted tactra penile prosthesis was too large.The patient received unspecified medication and was scheduled for a revision surgery.Boston scientific has been unable to obtain additional information regarding the patient outcome to date, despite good faith efforts.
 
Event Description
It was reported that the patient experienced worsening of urinary frequency after the implant surgery of the implanted tactra penile prosthesis.Thirty-six days after the onset procedure, the patient experienced discomfort and pain because the length of the implanted tactra penile prosthesis was too large.The patient received unspecified medication and was scheduled for a revision surgery.The patient underwent surgery fifty-one days after the implant procedure to replace the device with a smaller size implant.There were no further patient complications reported.
 
Manufacturer Narrative
There was no device available for analysis; therefore, no physical or visual analysis of the product could be performed.The reported patient symptoms are a known risk associated with implant of these devices as indicated in the instructions for use.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Event Description
It was reported that the patient experienced worsening of urinary frequency after the implant surgery of the implanted tactra penile prosthesis.Thirty-six days after the onset procedure, the patient experienced discomfort and pain because the length of the implanted tactra penile prosthesis was too large.The patient received unspecified medication and was scheduled for a revision surgery.The patient underwent surgery fifty-one days after the implant procedure to replace the device with a smaller size implant.There were no further patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTRA MALLEABLE PENILE PROTHESIS
Type of Device
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key18075694
MDR Text Key327473872
Report Number2124215-2023-62007
Device Sequence Number1
Product Code FAE
UDI-Device Identifier08714729979357
UDI-Public08714729979357
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number720081-01
Device Catalogue Number720081-01
Device Lot Number0040006889
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/20/2023
Initial Date FDA Received11/06/2023
Supplement Dates Manufacturer Received11/07/2023
12/11/2023
Supplement Dates FDA Received11/27/2023
12/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization; Required Intervention;
Patient Age74 YR
Patient SexMale
Patient RaceWhite
-
-